AI cash chases machines, sovereign data and pharma agents
Tuesday, July 7, 2026 · 8 min
Hive raised $15 million for industrial autonomy while B Capital closed a $500 million early-stage fund, as Sherpa.ai and Katalyze AI added fresh AI rounds around sovereign data and pharma operations.
Listen
Show notes
Hive raised $15 million for industrial autonomy while B Capital closed a $500 million early-stage fund, as Sherpa.ai and Katalyze AI added fresh AI rounds around sovereign data and pharma operations.
In this episode
- Hive raises $15m for ‘silicon brain’ that cuts hourly cost of running machines by 80% | Sifted — Sifted
# Hive raises $15m for ‘silicon brain’ that cuts hourly cost of running machines by 80% | Sifted Published: 2026-07-07T04:03:01+00:00 Source: sifted.eu (sifted.eu) Language: en ## Story Hive raises $15m for ‘silicon brain’ that cuts hourly cost of running machines by 80% | Sifted [Go to Homepage](https://sifted.eu/) [Go to Homepage](https://sifted.eu/) [Go to…
- B Capital Closes $500 Million Ascent Fund III to Back Early-Stage AI and Technology Companies | citybiz — citybiz
B Capital Closes $500 Million Ascent Fund III to Back Early-Stage AI and Technology Companies | citybiz B Capital has closed its third Ascent fund at its $500 million hard cap, nearly doubling the size of its predecessor as the global investment firm expands its commitment to early-stage technology companies developing artificial intelligence and other next-generation innovations. The fund was…
- Spain's Sherpa.ai raises $18M for data-sovereign AI — The Next Web
Spain's Sherpa.ai raises $18M for data-sovereign AI Everyone wants the power of AI. Few want to hand their most sensitive data to a foreign cloud to get it. A Basque startup thinks it has the fix. Sherpa.ai has raised $18m to build AI that never sees your raw data, tech.eu reported. The Spanish company sells to banks, hospitals and governments, the customers most nervous about where their data…
- Katalyze AI thinks the future of pharma operations is teams of AI agents | BetaKit — BetaKit
Katalyze AI thinks the future of pharma operations is teams of AI agents | BetaKit Canadian Tech & Startup News Canadian Tech & Startup News Katalyze AI co-founders Shreyas Becker and Reza Farahani. WFHomie co-founder and former Sanofi leader close $10.5 million USD to speed drug development. Katalyze AI announced $10.5 million USD ($14.9 million CAD) in seed funding on Monday to deploy its…